MGTX
MeiraGTx Holdings plc
NASDAQ · Healthcare · Biotechnology · US
$13.25
+1.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 42.32x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 48.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.43x
- PEG TTM
- —
- Price / book
- 5.90x
- Price / sales
- 3.20x
- Price / cash flow
- 92.96x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 3.12x
- EV / EBITDA
- 4.78x
- EV / EBIT
- 6.75x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026